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Abstract Peroxiredoxin (PRx) exhibits thioredoxin-dependent
peroxidase activity and constitutes a family of proteins. Four
members of genes from rat tissues were isolated by PCR using
degenerated primers based on the sequences which encode a pair
of highly conserved Cys-containing domains, and were then
cloned to full-length cDNAs. These included two genes which
have previously been isolated in rats, PRx I and PRx II, and two
rat homologues of PRx III and PRx IV. We showed, for the first
time, the simultaneous expression of all four genes in various rat
tissues by Northern blotting. Since a discrepancy exists
regarding cellular distribution, we further characterized PRx
IV by expressing it in COS-1 cells. This clearly demonstrates
that PRx IV is a secretory form and functions within the
extracellular space.
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1. Introduction
Oxidative stress is caused as the result of a variety of phys-
iological and pathophysiological conditions. Oxidative modi-
¢cations of biological molecules such as proteins, lipids, and
nucleic acids are potentially harmful to living organisms and
may contribute to aging [1]. Since thiol groups are highly
sensitive to oxidation, proteins in which thiol groups play a
key role represent an important target of oxidative stress.
Certain antioxidative enzymes such as the superoxide dismu-
tases (SODs) and glutathione peroxidases (GPxs), and antiox-
idant molecules such as glutathione and thioredoxin serve to
protect essential molecules against oxidative modi¢cation.
Recently, a novel family of proteins which function as anti-
oxidants, in the protection of thiol groups in proteins, has
been reported [2,3]. Since they also exhibit peroxidase activity
in a thioredoxin (TRx)-dependent manner, they are referred to
as peroxiredoxins (PRxs), and constitute a system which is
similar to the glutathione/GPx system [4]. Members of this
PRx family have two highly conserved Cys-containing do-
mains, and are distributed widely in nature from yeast cells
to mammalian tissues. Various biological e¡ects have been
reported with respect to these gene products in di¡erent spe-
cies. Three types of PRxs are known in mammals. PRx I has
heme binding capacity, and thus is called HBP [5,6]. This
protein also acts as a natural killer cell-enhancing factor
(NKEF-A) [7]. The second member of the PRx family, PRx
II, is also able to act as a natural killer cell-enhancing factor
(NKEF-B), and is often referred to as a thiol-speci¢c antiox-
idant (TSA) [8^10]. These two members of the gene family are
located in the cytosol. PRx III, which is found in mitochon-
dria, was originally reported to be an indispensable factor
involved in the di¡erentiation of mouse MEL cells (MER5,
now renamed AOP-1) [11]. This protein is also referred to as
SP-22 because it is a substrate protein for a mitochondrial
ATP-dependent protease [12]. The fourth member of the fam-
ily, PRx IV (AOE372) [13], has been cloned only quite re-
cently from human cells.
The issue of how many genes, and which member of the
genes, are expressed in a single mammalian species is currently
not clear. In this communication, we report on the PCR am-
pli¢cation of the PRx gene superfamily, using degenerated
primers which correspond to two highly conserved Cys-con-
taining domains, and the cloning of four cDNA members.
Since there is still considerable debate on the characteristics
of PRx IV, we further characterized this protein via its ex-
pression in COS-1 cells.
2. Materials and methods
2.1. Cell culture
COS-1 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% heat-inactivated fetal bovine serum (Gibco
BRL), 100 U/ml penicillin, and 100 U/ml streptomycin in a humid
atmosphere of 5% CO2 at 37‡C.
2.2. PCR using degenerated primers
Total cellular RNAs were prepared from rat tissues as described
previously [14]. Oligodeoxyribonucleotide primers were designed
based on the nucleotide sequences which encode the highly conserved
Cys-containing domains. These are Px1, 5P-ACNTTTGTGTGYC-
CYACNGA-3P and Px2, 5P-GCNGGRCANACTTCNCCATG-3P
(N = G, A, T, or C; Y = C or T; R = A or G). Single strand cDNAs
were synthesized from 10 Wg total RNA and used as templates for
PCR at 94‡C for 30 s, 55‡C for 60 s, and 72‡C for 90 s for 25 cycles.
This ampli¢ed an about 460 bp DNA fragment. These were subcloned
into a pT7 Blue-T vector (Novagen) and sequenced using a computer-
assisted automated sequencer (DSQ-1000L, Shimadzu). A homology
search was executed on the BLAST/FASTA program provided via
Internet by the National Library of Medicine, NIH (USA).
2.3. Isolation of cDNAs and genomic clones
About 106 independent plaques from a rat kidney cDNA library
constructed in Vgt10 [15] were screened with PRx probes labelled with
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a random priming kit (Amersham) and [K-32P]dCTP (Amersham).
The 5P end of the rat PRx IV was cloned by the rapid ampli¢cation
of cDNA ends (RACE) method using a Marathon cDNA ampli¢ca-
tion kit (Clontech), since it was not possible to isolate a V phage clone
containing the 5P region from the cDNA library. 10 Wg of total RNA,
isolated from rat liver, was reverse-transcribed with RAV-2 (Takara
Co.) using the Px2 primer. After ligation of the 5P adapter to the end
of the reverse transcribed product, PCR was performed by using the
5P adapter primer (5P-CCATCCTAATACGACTCACTATAGGGC-
3P) and the gene-speci¢c primer (5P-CCAAGTATTTCCCACGA-
TAGTCGGT-3P). The 409 bp PCR products were subcloned into
pT7 Blue-T vector and the nucleotide sequences determined for ¢ve
independent clones. All were found to be identical. This cDNA frag-
ment was ligated to the 5P end of the partial PRx IV cDNA to con-
struct full length cDNA. To isolate PRx IV genomic clones, 106 pla-
ques of a VDASH II human genomic library (Stratagene) were
screened with the rat cDNA fragment under high stringency condi-
tions.
2.4. Fluorescence in situ hybridization (FISH)
FISH was performed on human R-banded metaphase chromosomes
as described previously [16]. The isolated V phage clone was labelled
with biotin-16-dUTP using a nick-translation kit (Boehringer-Mann-
heim, Germany). Hybridized signals were observed under a £uores-
cence microscope with ¢lters B2-A and B2-E (Nikon, Japan).
2.5. Northern blotting
Twenty microgram of total RNA was electrophoresed on a 1%
agarose gel containing 2.2 M formaldehyde. The size-fractionated
RNAs were transferred onto a Zeta-Probe membrane (Bio-Rad) by
capillary action. After hybridization with the 32P-labelled PRx probes
at 42‡C in the presence of 50% formamide, the membrane was washed
at 55‡C in 2USSC (1USSC: 150 mM NaCl and 15 mM sodium
citrate, pH 7.5) containing 0.1% sodium dodecyl sulfate (SDS) for
80 min. The Kodak XAR ¢lms were exposed for 2 days with an
intensifying screen at 380‡C.
2.6. Preparation of anti-PRx IV antibodies
A portion of PRx IV cDNA encoding 175 amino acids, which
encompasses the entire carboxy-terminal region, was ligated to a plas-
mid pMAL-c (New England BioLabs) and the fusion protein with
maltose binding protein (MBP-PRx IV) was expressed in Escherichia
coli. MBP-PRx IV was puri¢ed using an amylose resin a⁄nity column
(New England BioLabs) according to the manufacturer’s instructions.
The puri¢ed MBP-PRx IV was digested with Factor Xa (New Eng-
land BioLabs) and separated from MBP by an AcA54 gel ¢ltration
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Fig. 1. Alignment of amino acid sequences among rat PRxs. The amino acid sequences applied for synthesizing degenerated oligonucleotide pri-
mers are underlined. Conserved, essential Cys residues are marked with asterisks. White letters in black boxes indicate the conserved residues
among the family members. Nucleotide sequences for rat PRx III and PRx IV were deposited to GenBank with accession numbers AF106944
and AF106945, respectively.
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column. Female rabbits were immunized subcutaneously with 200 Wg
PRx IV protein in Freund’s complete adjuvant. The rabbit was bled
2 weeks after the last immunization. The IgG fraction was puri¢ed
from the anti-sera by fractionation with ammonium sulfate. This anti-
PRx IV IgG speci¢cally recognized PRx IV.
2.7. Expression of PRx IV in COS-1 cells and immuno£uorescent
staining
Full length PRx IV cDNA was ligated into the pSVK3 expression
vector carrying an SV40 early promoter (Amersham/Pharmacia Bio-
tech). 50 Wg of CsCl-puri¢ed pSVK3-PRx IV cDNA was transfected
into COS-1 cells by the electroporation method using Gene Pulser
(Bio-Rad) under conditions of 220 V and 960 WF in ice cold
HEPES-bu¡ered saline, pH 6.95. Six hours after transfection, the
culture medium was replaced with fresh medium. At 48 h after trans-
fection, culture media and transfected cells were harvested and used
for immunoblot analyses. The chemiluminescence method was em-
ployed to amplify the signal using an ECL kit (Amersham).
For immuno£uorescent staining, PRx IV cDNA-transfected COS-1
cells were seeded on a glass coverslip and cultured for 48 h. They were
washed twice with phosphate-bu¡ered saline (PBS), ¢xed with 4%
paraformaldehyde for 30 min at 27‡C, washed 3 times, and then
incubated overnight with 1:500 diluted anti-rat PRx IV antibody in
the permeabilization solution (0.2% Triton X-100, 3% BSA, and
0.05% sodium azide in 10 ml PBS) at 4‡C. The samples were then
washed 3 times with PBS, and incubated with £uorescein isothiocya-
nate (FITC)-conjugated anti-rabbit IgG at room temperature for 2 h.
After washing 3 times with PBS, the cells on the coverslip were
mounted on a slide glass and examined by £uorescence microscopy
(AX70, Olympus).
3. Results
3.1. PCR ampli¢cation of a gene family using degenerated
primers and cloning full length PRx cDNAs
A homology search on the reported amino acid sequences
of members of PRx gene superfamily showed several highly
homologous regions, especially two domains with essential
Cys residues [4]. We designed degenerated primers Px1 and
Px2, based on the nucleotide sequences which encode a pair of
highly conserved Cys-containing domains, and ampli¢ed
about 460 bp cDNAs which had been reverse transcribed
from total RNAs extracted from rat brain and liver using
these primers. As a result, we obtained cDNA fragments cov-
ering four members of the clones in the PRx gene superfamily.
A rat kidney cDNA library [15] was screened with these
DNA fragments as probes and full length clones for three
genes were obtained, corresponding to rat homologues of
PRx I, PRx II, and PRx III. PRx I and II have previously
been reported in rats, and PRx III represents a rat homologue
reported in mouse. Since the fourth clone lacked the 5P region,
5P-RACE was carried out to isolate the full length clone. The
resultant clone was novel when cloned by us, but its human
homologue was recently reported and referred to as AOE372
[13].
We then screened about 106 V phages from a human ge-
nomic DNA library constructed in VDASH II using a rat PRx
IV cDNA fragment as a probe and isolated three independent
clones. Since the gene loci of three members of PRx except for
PRx IV are already known [11,17,18], one of the genomic
clones was used as a probe for FISH analysis on human
R-banded metaphase chromosomes. This identi¢ed the human
PRx IV unambiguously on chromosome Xp21.3 (data not
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Fig. 2. Di¡erential expression of PRx mRNAs in various tissues in
rats. Total RNA (20 Wg), isolated from 11 tissues of Sprague-Daw-
ley rats at 14 weeks of age, were analyzed by Northern blotting us-
ing speci¢c probes for rat PRxs genes. Lane 1: brain, 2: lung, 3:
heart, 4: liver, 5: spleen, 6: stomach, 7: kidney, 8: small intestine,
9: colon, 10: skeletal muscle, 11: testis. The quality of RNA as
judged by 18S rRNA was about the same in all samples. Samples
from ¢ve di¡erent rats were analyzed and typical data are shown.
Fig. 3. Immunoblot analysis of PRx IV protein transiently expressed
in COS-1 cells. pSVK3 expression vector carrying entire rat PRx IV
cDNA was transfected into COS-1 cells by electroporation. 20 Wg of
proteins from a cell lysate or 10 Wl of culture medium were sepa-
rated on SDS-PAGE and then transferred onto nitrocellulose mem-
brane. Anti-PRx IV IgG and peroxidase-conjugated anti-rabbit IgG
were used as primary and secondary antibodies, respectively. The
chemiluminescence method was employed to amplify the signal us-
ing an ECL kit.
Fig. 4. Immuno£uorescent staining of PRx IV expressed in COS-1
cells. After transfection of COS-1 cells with rat PRx IV cDNA, they
were reacted with anti-PRx IV IgG. FITC-labelled anti-rabbit IgG
was used as the secondary antibody. The cells were examined by
£uorescent microscopy (U360).
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shown), which is consistent with a recent report on this sub-
ject [19].
3.2. Characteristics of PRx proteins
Deduced amino acid sequences of these genes showed con-
siderable similarity throughout the molecules, especially the
two domains which contain essential Cys residues (Fig. 1).
Hydropathy pro¢les of these gene products also con¢rmed
the resemblance of their sizes and hydrophobicities except
for the amino-termini of PRx III and PRx IV. Since mouse
PRx III has been reported to be a mitochondrial protein, the
extended amino-terminal sequences could act as a leader pep-
tide for mitochondrial import. On the other hand, the amino-
terminal hydrophobic stretch in PRx IV was typical for the
signal sequence of secretory proteins or the transmembrane
K-helix of type II membrane proteins.
3.3. Di¡erential expression of PRx mRNAs in rat tissues
Although numerous functions have been reported for the
PRx proteins, their actual physiological roles in each organ
are still in debate. To understand the physiological role of
PRx isozymes in individual tissues, we compared their multi-
plex expression in 11 tissues by using speci¢c probes for all
four isozymes and Northern blotting (Fig. 2). Samples from
¢ve di¡erent rats were analyzed and typical data are shown.
PRx I, which was originally found to be a major heme binding
protein in liver, showed higher levels of expression in liver,
kidney, and small intestine than other tissues. Expression of
PRx II was higher in heart, brain, and spleen, but lower in
liver. PRx III was expressed at high levels in heart, skeletal
muscle, and kidney, which are all rich in mitochondria. PRx
IV was highly expressed in liver and testis. Thus all four iso-
forms appear to be expressed rather ubiquitously, although
enhanced expression was observed for a particular isoform
in some tissues.
3.4. Characteristics of PRx IV expressed in COS-1 cells
Since PRx IV contains the amino-terminal hydrophobic
stretch, the possibility exists that post-translational processing
could occur. To investigate the property of PRx IV, we at-
tempted an immunoblot analysis of various cell lines, but
failed to detect reliable signals, probably due to the low level
of expression of PRx IV in these cells (data not shown). We
then performed the transient expression of PRx IV in COS-1
cells. We carried out immunoblot analyses of cell lysates and
conditioned medium using a speci¢c anti-PRx IV antibody
(Fig. 3). While untransfected COS-1 cells showed no detect-
able PRx IV protein in either the cell lysate or the conditioned
medium, PRx IV cDNA-transfected cells clearly displayed
speci¢c bands corresponding to both of these. The size of
the resultant PRx IV protein was 30 kDa, which corresponds
to that of PRx IV truncated at the C-terminus of the amino-
terminal hydrophobic stretch.
To determine the localization of the expressed PRx IV in
cells, we then performed immuno£uorescent staining. When
COS-1 cells transfected with PRx IV cDNA were examined,
an intracellular network-like structure, which is typical for
endoplasmic reticulum (ER), was observed (Fig. 4). No stain-
ing of the plasma membrane or nuclei was observed. Untrans-
fected COS-1 cells, used as controls, showed no signals. These
data are completely consistent with the nature of PRx IV as a
secretory protein.
4. Discussion
PRx has been characterized as a Trx-dependent peroxidase
[4]. The PRx family have been cloned in various organisms
from prokaryotes to mammalians [2,10]. Two domains, which
contain essential Cys residues, responsible for their antioxi-
dant activities were highly conserved among di¡erent species.
Although a variety of functions has been reported for these
gene products, the issue of how many genes exist in a single
mammalian species, and which members of the genes are ex-
pressed in individual tissues remains unclear. In this commu-
nication, we report the cloning of two additional rat homo-
logues and show that at least four PRxs are simultaneously
expressed in rat tissues. While PRx I and II are cytoplasmic
proteins [5,8], PRx III is localized in mitochondria [12]. The
expression of PRx III was abundant in tissues that are rich in
mitochondria, such as heart, kidney, and skeletal muscle, and
whose oxygen consumption is relatively high. Since mitochon-
dria are the main intracellular organelles which consume mo-
lecular oxygen by respiration, PRx III may function in concert
with Mn-SOD to scavenge reactive oxygen species (ROS)
which leak from the electron transport chain.
This study focused on PRx IV, whose human homologue
was reported quite recently by two groups. Jin et al. [13]
identi¢ed the gene product within cells, with a similar local-
ization to PRx I, and concluded that it was a cytoplasmic
protein. However, its hydropathy pro¢le clearly showed a
hydrophobic stretch at the N-terminus, which is typically
found in secretory or type II transmembrane proteins. Har-
idas et al. [19] actually identi¢ed PRx IV in conditioned me-
dium of Jurkat and HL60 cells. When we transfected COS-1
cells with PRx IV cDNA, immunoreactive bands to anti-PRx
IV IgG were detected in both the conditioned medium and a
cellular extract. Its size, 30 kDa, was smaller than the pre-
dicted size from the cDNA sequences but corresponded to the
truncated polypeptide after the hydrophobic stretch. Thus, the
recombinant PRx IV is probably processed to a secretory
form post-translationally. Immuno£uorescent staining of the
cDNA-transfected cells gave a staining pattern which was
typical for an ER structure (Fig. 4). Since the molecular size
of the intracellular PRx IV was the same as that of the se-
creted one (Fig. 3), it is also predicted to exist as a truncated
and soluble form in the ER, but not as a membrane-bound
form. It is, therefore, conceivable that the protein which is
localized in the ER is in the process of secretion as is com-
monly observed for other secretory proteins. Accordingly, we
conclude that PRx IV represents the secretory form of the
PRx family.
Among the functions reported for other members of the
PRx gene products, only TRx-dependent peroxidase activity
is commonly accepted as the enzymatic activity [20]. The same
activity has also been reported for the human PRx IV homo-
logue [13]. It is well established that signi¢cant amounts of
TRx and TRx reductase are present in the extracellular space
[21]. Hence, PRx IV would be able to function as a TRx-
dependent peroxidase within the extracellular space in a man-
ner similar to other antioxidant enzymes, such as plasma GPx
and extracellular SOD. Since it is well known that the liver
produces many plasma proteins such as albumin and trans-
ferrin, and expresses high levels of PRx IV mRNA, PRx IV
may be secreted into plasma from the liver, thus protecting
the vascular system from ROS.
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Although Haridas et al. [19] reported in£ammatory cyto-
kine-like activities, such as the activation of NF-UB and the
induction of nitric oxide synthase (NOS II), for PRx IV, an
opposite e¡ect was reported by Jin et al. [13] who showed
suppression of NF-UB DNA binding activity in AOE372-
overexpressing cells. In our preliminary experiment, recombi-
nant rat PRx IV produced in a baculovirus/insect cell system
did not induce NO production in RAW264.7 cells (Okado et
al., submitted). Thus, a discrepancy remains as to its function.
Further experiments will be required to solve these problems,
and to comprehend the actual role of PRx IV in vivo.
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